136 related articles for article (PubMed ID: 31651346)
1. Functional characterization of canine wild type glucocorticoid receptor and an insertional mutation in a dog.
Yamanaka K; Okuda M; Mizuno T
BMC Vet Res; 2019 Oct; 15(1):363. PubMed ID: 31651346
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid sensitivity depends on expression levels of glucocorticoid receptors in canine neoplastic mast cells.
Matsuda A; Tanaka A; Amagai Y; Ohmori K; Nishikawa S; Xia Y; Karasawa K; Okamoto N; Oida K; Jang H; Matsuda H
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):321-8. PubMed ID: 21908058
[TBL] [Abstract][Full Text] [Related]
3. Three Novel Heterozygous Point Mutations of NR3C1 Causing Glucocorticoid Resistance.
Vitellius G; Fagart J; Delemer B; Amazit L; Ramos N; Bouligand J; Le Billan F; Castinetti F; Guiochon-Mantel A; Trabado S; Lombès M
Hum Mutat; 2016 Aug; 37(8):794-803. PubMed ID: 27120390
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain.
Vreugdenhil E; Verissimo CS; Mariman R; Kamphorst JT; Barbosa JS; Zweers T; Champagne DL; Schouten T; Meijer OC; de Kloet ER; Fitzsimons CP
Endocrinology; 2009 May; 150(5):2220-8. PubMed ID: 19131573
[TBL] [Abstract][Full Text] [Related]
5. Iatrogenic Cushing's syndrome in a dog from owner's topical corticosteroid.
Ridgway HB; Moriello KA
Arch Dermatol; 1993 Mar; 129(3):379. PubMed ID: 8447682
[No Abstract] [Full Text] [Related]
6. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia in a dog with resolution of iatrogenic Cushing's syndrome.
Nakamura M; Kawamura Y; Minegishi M; Momoi Y; Iwasaki T
J Vet Med Sci; 2004 Mar; 66(3):329-31. PubMed ID: 15107569
[TBL] [Abstract][Full Text] [Related]
8. Hypophyseal-adrenocortical function in experimental iatrogenic canine Cushing's syndrome.
Komiyama N; Tsumagari S; Ohba S; Takagi K; Satoh S; Takeishi M
J Vet Med Sci; 1991 Apr; 53(2):351-3. PubMed ID: 1650606
[No Abstract] [Full Text] [Related]
9. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.
Ruiz M; Lind U; Gåfvels M; Eggertsen G; Carlstedt-Duke J; Nilsson L; Holtmann M; Stierna P; Wikström AC; Werner S
Clin Endocrinol (Oxf); 2001 Sep; 55(3):363-71. PubMed ID: 11589680
[TBL] [Abstract][Full Text] [Related]
10. Familial glucocorticoid resistance caused by a novel frameshift glucocorticoid receptor mutation.
Trebble P; Matthews L; Blaikley J; Wayte AW; Black GC; Wilton A; Ray DW
J Clin Endocrinol Metab; 2010 Dec; 95(12):E490-9. PubMed ID: 20861124
[TBL] [Abstract][Full Text] [Related]
11. Restrained expression of canine glucocorticoid receptor splice variants α and P prognosticates fatal disease outcome in SIRS.
Kállai BM; Csöndes J; Kiss G; Bodrogi L; Rónai Z; Mészáros T
Sci Rep; 2021 Dec; 11(1):24505. PubMed ID: 34969952
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of Glucocorticoid Signaling.
Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
[TBL] [Abstract][Full Text] [Related]
13. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance.
Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC
Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271
[TBL] [Abstract][Full Text] [Related]
14. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier.
Boivin MA; Ye D; Kennedy JC; Al-Sadi R; Shepela C; Ma TY
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G590-8. PubMed ID: 17068119
[TBL] [Abstract][Full Text] [Related]
16. Evolution of glucocorticoid receptors with different glucocorticoid sensitivity.
Stolte EH; van Kemenade BM; Savelkoul HF; Flik G
J Endocrinol; 2006 Jul; 190(1):17-28. PubMed ID: 16837607
[TBL] [Abstract][Full Text] [Related]
17. Effect of glucocorticoid administration on adrenal gland size and sonographic appearance in beagle dogs.
Pey P; Daminet S; Smets PM; Duchateau L; Travetti O; Saunders JH
Vet Radiol Ultrasound; 2012; 53(2):204-9. PubMed ID: 22092685
[TBL] [Abstract][Full Text] [Related]
18. A hotspot in the glucocorticoid receptor DNA-binding domain susceptible to loss of function mutation.
Banuelos J; Shin SC; Lu NZ
Steroids; 2015 Apr; 96():115-20. PubMed ID: 25676786
[TBL] [Abstract][Full Text] [Related]
19. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation.
Karl M; Lamberts SW; Koper JW; Katz DA; Huizenga NE; Kino T; Haddad BR; Hughes MR; Chrousos GP
Proc Assoc Am Physicians; 1996 Jul; 108(4):296-307. PubMed ID: 8863343
[TBL] [Abstract][Full Text] [Related]
20. Cloning of a teleost fish glucocorticoid receptor shows that it contains a deoxyribonucleic acid-binding domain different from that of mammals.
Ducouret B; Tujague M; Ashraf J; Mouchel N; Servel N; Valotaire Y; Thompson EB
Endocrinology; 1995 Sep; 136(9):3774-83. PubMed ID: 7649084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
